カテゴリー： GlobalInfoResearch, 世界, 医療/バイオ

羊＆山羊ワクチンのグローバル市場2023：弱毒生ワクチン、不活化ワクチン、その他

◆英語タイトル：Global Sheep and Goat Vaccines Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
	◆商品コード：GIR23JU624 ◆発行会社（リサーチ会社）：GlobalInfoResearch ◆発行日：2023年6月 ◆ページ数：101 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（注文後2-3日） ◆調査対象地域：グローバル ◆産業分野：医薬品＆医療

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,480 ⇒換算￥528,960	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD5,220 ⇒換算￥793,440	見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）	USD6,960 ⇒換算￥1,057,920	見積依頼/購入/質問フォーム

★GlobalInfoResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Info Research社の最新の調査によると、羊＆山羊ワクチンのグローバル市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
本調査レポートは、世界の羊＆山羊ワクチン市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。

市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。

本資料の主な目的は次のとおりです。
- 世界および主要国の市場機会の規模を決定するため
- 羊＆山羊ワクチンの成長可能性を評価するため
- 各製品および最終用途市場の将来の成長を予測するため
- 市場に影響を与える競争要因を評価するため

羊＆山羊ワクチン市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメント
・弱毒生ワクチン、不活化ワクチン、その他

用途別セグメント
・羊、ヤギ

主要な市場プレーヤー
・Merck、Zoetis、Boehringer Ingelheim、Ceva、CAHIC、HVRI、Ringpu Biology、Yebio、DHN、WINSUN、Elanco、Virbac

地域別セグメントは次の地域・国をカバーします。
・北米（アメリカ、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、羊＆山羊ワクチン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な羊＆山羊ワクチンメーカーの企業概要、2019年～2022年までの羊＆山羊ワクチンの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な羊＆山羊ワクチンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別羊＆山羊ワクチンの販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までの羊＆山羊ワクチンの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域での羊＆山羊ワクチン市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、および羊＆山羊ワクチンの産業チェーンを掲載しています。
・第14、15章では、羊＆山羊ワクチンの販売チャネル、販売業者、顧客、調査結果について説明します。

***** 目次(一部) *****

・市場概要
- 羊＆山羊ワクチンの概要
- 種類別分析（2018年vs2022年vs2029年）：弱毒生ワクチン、不活化ワクチン、その他
- 用途別分析（2018年vs2022年vs2029年）：羊、ヤギ
- 世界の羊＆山羊ワクチン市場規模・予測
- 世界の羊＆山羊ワクチン生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Merck、Zoetis、Boehringer Ingelheim、Ceva、CAHIC、HVRI、Ringpu Biology、Yebio、DHN、WINSUN、Elanco、Virbac
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・種類別分析2018年-2029年：弱毒生ワクチン、不活化ワクチン、その他
・用途別分析2018年-2029年：羊、ヤギ
・羊＆山羊ワクチンの北米市場
- 種類別市場規模2018年-2029年
- 用途別市場規模2018年-2029年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・羊＆山羊ワクチンのヨーロッパ市場
- 種類別市場規模2018年-2029年
- 用途別市場規模2018年-2029年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・羊＆山羊ワクチンのアジア市場
- 種類別市場規模2018年-2029年
- 用途別市場規模2018年-2029年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・羊＆山羊ワクチンの南米市場
- 種類別市場規模2018年-2029年
- 用途別市場規模2018年-2029年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・羊＆山羊ワクチンの中東・アフリカ市場
- 種類別市場規模2018年-2029年
- 用途別市場規模2018年-2029年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

According to our (Global Info Research) latest study, the global Sheep and Goat Vaccines market size was valued at USD 1050.6 million in 2022 and is forecast to a readjusted size of USD 1623.1 million by 2029 with a CAGR of 6.4% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Sheep and goat vaccines are vaccines that are specifically designed for use in sheep and goats to prevent various diseases that can affect these animals. Some of the commonly used sheep and goat vaccines include those for diseases such as Clostridial diseases like Tetanus and Pulpy Kidney, Foot Rot, Pasteurella, and Contagious Ecthyma (Orf). These vaccines are typically administered via injection ingestion and are an important tool for maintaining the health and productivity of sheep and goat herds.
This report is a detailed and comprehensive analysis for global Sheep and Goat Vaccines market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Sheep and Goat Vaccines market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Sheep and Goat Vaccines market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Sheep and Goat Vaccines market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Sheep and Goat Vaccines market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Sheep and Goat Vaccines
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Sheep and Goat Vaccines market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, Zoetis, Boehringer Ingelheim, Ceva and CAHIC, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Sheep and Goat Vaccines market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Live Attenuated Vaccines
Inactivated Vaccines
Other
Market segment by Application
Sheep
Goat
Major players covered
Merck
Zoetis
Boehringer Ingelheim
Ceva
CAHIC
HVRI
Ringpu Biology
Yebio
DHN
WINSUN
Elanco
Virbac
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Sheep and Goat Vaccines product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Sheep and Goat Vaccines, with price, sales, revenue and global market share of Sheep and Goat Vaccines from 2018 to 2023.
Chapter 3, the Sheep and Goat Vaccines competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Sheep and Goat Vaccines breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Sheep and Goat Vaccines market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Sheep and Goat Vaccines.
Chapter 14 and 15, to describe Sheep and Goat Vaccines sales channel, distributors, customers, research findings and conclusion.

❖ レポートの目次 ❖

1 Market Overview
1.1 Product Overview and Scope of Sheep and Goat Vaccines
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Sheep and Goat Vaccines Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Live Attenuated Vaccines
1.3.3 Inactivated Vaccines
1.3.4 Other
1.4 Market Analysis by Application
1.4.1 Overview: Global Sheep and Goat Vaccines Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Sheep
1.4.3 Goat
1.5 Global Sheep and Goat Vaccines Market Size & Forecast
1.5.1 Global Sheep and Goat Vaccines Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Sheep and Goat Vaccines Sales Quantity (2018-2029)
1.5.3 Global Sheep and Goat Vaccines Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck Sheep and Goat Vaccines Product and Services
2.1.4 Merck Sheep and Goat Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Merck Recent Developments/Updates
2.2 Zoetis
2.2.1 Zoetis Details
2.2.2 Zoetis Major Business
2.2.3 Zoetis Sheep and Goat Vaccines Product and Services
2.2.4 Zoetis Sheep and Goat Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Zoetis Recent Developments/Updates
2.3 Boehringer Ingelheim
2.3.1 Boehringer Ingelheim Details
2.3.2 Boehringer Ingelheim Major Business
2.3.3 Boehringer Ingelheim Sheep and Goat Vaccines Product and Services
2.3.4 Boehringer Ingelheim Sheep and Goat Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Boehringer Ingelheim Recent Developments/Updates
2.4 Ceva
2.4.1 Ceva Details
2.4.2 Ceva Major Business
2.4.3 Ceva Sheep and Goat Vaccines Product and Services
2.4.4 Ceva Sheep and Goat Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Ceva Recent Developments/Updates
2.5 CAHIC
2.5.1 CAHIC Details
2.5.2 CAHIC Major Business
2.5.3 CAHIC Sheep and Goat Vaccines Product and Services
2.5.4 CAHIC Sheep and Goat Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 CAHIC Recent Developments/Updates
2.6 HVRI
2.6.1 HVRI Details
2.6.2 HVRI Major Business
2.6.3 HVRI Sheep and Goat Vaccines Product and Services
2.6.4 HVRI Sheep and Goat Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 HVRI Recent Developments/Updates
2.7 Ringpu Biology
2.7.1 Ringpu Biology Details
2.7.2 Ringpu Biology Major Business
2.7.3 Ringpu Biology Sheep and Goat Vaccines Product and Services
2.7.4 Ringpu Biology Sheep and Goat Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Ringpu Biology Recent Developments/Updates
2.8 Yebio
2.8.1 Yebio Details
2.8.2 Yebio Major Business
2.8.3 Yebio Sheep and Goat Vaccines Product and Services
2.8.4 Yebio Sheep and Goat Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Yebio Recent Developments/Updates
2.9 DHN
2.9.1 DHN Details
2.9.2 DHN Major Business
2.9.3 DHN Sheep and Goat Vaccines Product and Services
2.9.4 DHN Sheep and Goat Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 DHN Recent Developments/Updates
2.10 WINSUN
2.10.1 WINSUN Details
2.10.2 WINSUN Major Business
2.10.3 WINSUN Sheep and Goat Vaccines Product and Services
2.10.4 WINSUN Sheep and Goat Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 WINSUN Recent Developments/Updates
2.11 Elanco
2.11.1 Elanco Details
2.11.2 Elanco Major Business
2.11.3 Elanco Sheep and Goat Vaccines Product and Services
2.11.4 Elanco Sheep and Goat Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Elanco Recent Developments/Updates
2.12 Virbac
2.12.1 Virbac Details
2.12.2 Virbac Major Business
2.12.3 Virbac Sheep and Goat Vaccines Product and Services
2.12.4 Virbac Sheep and Goat Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Virbac Recent Developments/Updates
3 Competitive Environment: Sheep and Goat Vaccines by Manufacturer
3.1 Global Sheep and Goat Vaccines Sales Quantity by Manufacturer (2018-2023)
3.2 Global Sheep and Goat Vaccines Revenue by Manufacturer (2018-2023)
3.3 Global Sheep and Goat Vaccines Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Sheep and Goat Vaccines by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Sheep and Goat Vaccines Manufacturer Market Share in 2022
3.4.2 Top 6 Sheep and Goat Vaccines Manufacturer Market Share in 2022
3.5 Sheep and Goat Vaccines Market: Overall Company Footprint Analysis
3.5.1 Sheep and Goat Vaccines Market: Region Footprint
3.5.2 Sheep and Goat Vaccines Market: Company Product Type Footprint
3.5.3 Sheep and Goat Vaccines Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Sheep and Goat Vaccines Market Size by Region
4.1.1 Global Sheep and Goat Vaccines Sales Quantity by Region (2018-2029)
4.1.2 Global Sheep and Goat Vaccines Consumption Value by Region (2018-2029)
4.1.3 Global Sheep and Goat Vaccines Average Price by Region (2018-2029)
4.2 North America Sheep and Goat Vaccines Consumption Value (2018-2029)
4.3 Europe Sheep and Goat Vaccines Consumption Value (2018-2029)
4.4 Asia-Pacific Sheep and Goat Vaccines Consumption Value (2018-2029)
4.5 South America Sheep and Goat Vaccines Consumption Value (2018-2029)
4.6 Middle East and Africa Sheep and Goat Vaccines Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Sheep and Goat Vaccines Sales Quantity by Type (2018-2029)
5.2 Global Sheep and Goat Vaccines Consumption Value by Type (2018-2029)
5.3 Global Sheep and Goat Vaccines Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Sheep and Goat Vaccines Sales Quantity by Application (2018-2029)
6.2 Global Sheep and Goat Vaccines Consumption Value by Application (2018-2029)
6.3 Global Sheep and Goat Vaccines Average Price by Application (2018-2029)
7 North America
7.1 North America Sheep and Goat Vaccines Sales Quantity by Type (2018-2029)
7.2 North America Sheep and Goat Vaccines Sales Quantity by Application (2018-2029)
7.3 North America Sheep and Goat Vaccines Market Size by Country
7.3.1 North America Sheep and Goat Vaccines Sales Quantity by Country (2018-2029)
7.3.2 North America Sheep and Goat Vaccines Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Sheep and Goat Vaccines Sales Quantity by Type (2018-2029)
8.2 Europe Sheep and Goat Vaccines Sales Quantity by Application (2018-2029)
8.3 Europe Sheep and Goat Vaccines Market Size by Country
8.3.1 Europe Sheep and Goat Vaccines Sales Quantity by Country (2018-2029)
8.3.2 Europe Sheep and Goat Vaccines Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Sheep and Goat Vaccines Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Sheep and Goat Vaccines Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Sheep and Goat Vaccines Market Size by Region
9.3.1 Asia-Pacific Sheep and Goat Vaccines Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Sheep and Goat Vaccines Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Sheep and Goat Vaccines Sales Quantity by Type (2018-2029)
10.2 South America Sheep and Goat Vaccines Sales Quantity by Application (2018-2029)
10.3 South America Sheep and Goat Vaccines Market Size by Country
10.3.1 South America Sheep and Goat Vaccines Sales Quantity by Country (2018-2029)
10.3.2 South America Sheep and Goat Vaccines Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Sheep and Goat Vaccines Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Sheep and Goat Vaccines Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Sheep and Goat Vaccines Market Size by Country
11.3.1 Middle East & Africa Sheep and Goat Vaccines Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Sheep and Goat Vaccines Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Sheep and Goat Vaccines Market Drivers
12.2 Sheep and Goat Vaccines Market Restraints
12.3 Sheep and Goat Vaccines Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Sheep and Goat Vaccines and Key Manufacturers
13.2 Manufacturing Costs Percentage of Sheep and Goat Vaccines
13.3 Sheep and Goat Vaccines Production Process
13.4 Sheep and Goat Vaccines Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Sheep and Goat Vaccines Typical Distributors
14.3 Sheep and Goat Vaccines Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 羊＆山羊ワクチンのグローバル市場2023：弱毒生ワクチン、不活化ワクチン、その他(Global Sheep and Goat Vaccines Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

羊＆山羊ワクチンのグローバル市場2023：弱毒生ワクチン、不活化ワクチン、その他

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp